GLENMARK
Invest with MTF
Invest Now
Invest in Glenmark Pharmaceuticals with 3.41X leverage
Performance
- Low
- ₹2,004
- High
- ₹2,026
- 52 Week Low
- ₹1,276
- 52 Week High
- ₹2,285
- Open Price₹2,018
- Previous Close₹2,020
- Volume206,579
Investment Returns
- Over 1 Month + 3.43%
- Over 3 Month + 1.97%
- Over 6 Month + 17.5%
- Over 1 Year + 26.78%
Smart Investing Starts Here Start SIP with Glenmark Pharmaceuticals for Steady Growth!
Glenmark Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 56.2
- PEG Ratio
- 0.3
- Market Cap Cr
- 56,739
- P/B Ratio
- 5.9
- Average True Range
- 41.38
- EPS
- 89.11
- Dividend Yield
- 0.2
- MACD Signal
- 25.7
- RSI
- 59.85
- MFI
- 54.62
Glenmark Pharmaceuticals Financials
Glenmark Pharmaceuticals Technicals
EMA & SMA
Current Price
₹2,010.60
-9.5
(-0.47%)
- Bearish Moving Average 2
- Bullish Moving Average 14
- 20 Day
- ₹1,972.47
- 50 Day
- ₹1,942.27
- 100 Day
- ₹1,911.74
- 200 Day
- ₹1,814.40
Resistance and Support
2013.6
- R3 2,044.50
- R2 2,035.20
- R1 2,022.90
- S1 2,001.30
- S2 1,992.00
- S3 1,979.70
Glenmark Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Glenmark Pharmaceuticals F&O
About Glenmark Pharmaceuticals
- NSE Symbol
- GLENMARK
- BSE Symbol
- 532296
- Chairman & Managing Director
- Mr. Glenn Saldanha
- ISIN
- INE935A01035
Similar Stocks to Glenmark Pharmaceuticals
Glenmark Pharmaceuticals FAQs
Glenmark Pharmaceuticals share price is ₹2,010 As on 29 December, 2025 | 04:17
The Market Cap of Glenmark Pharmaceuticals is ₹56739.3 Cr As on 29 December, 2025 | 04:17
The P/E ratio of Glenmark Pharmaceuticals is 56.2 As on 29 December, 2025 | 04:17
The PB ratio of Glenmark Pharmaceuticals is 5.9 As on 29 December, 2025 | 04:17
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.